S. Doron

669 citations

18 papers · 554 indexed · h-index 9

Impact in

Hepatology top 5%
- Liver physiology and pathology
- Liver Diseases and Immunity
- Liver Disease and Transplantation
Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- IL-33, ST2, and ILC Pathways

Papers in

Hepatology 8
- Liver physiology and pathology 8
- Liver Diseases and Immunity 3
Immunology 8
- Immune Cell Function and Interaction 7
- T-cell and B-cell Immunology 2

Co-authors: Rifaat Safadi Amjad Horani Nidal Muhanna Johnny Amer Mahmud Mahamid Chamutal Gur E. Philip Horwitz Shlomit Kfir‐Erenfeld
Journals: Journal of Hepatology (2 papers)Gut (2 papers)Mitochondrion (2 papers)Clinical & Experimental Immunology (2 papers)American Journal of Physiology-Gastrointestinal and Liver Physiology (2 papers)
Partner nations: Israel United States Palestinian Territory

In The Last Decade

S. Doron

18 papers receiving 551 citations

Peers

Countries citing papers authored by S. Doron

Since Specialization

Citations

This map shows the geographic impact of S. Doron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Doron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Doron more than expected).

Fields of papers citing papers by S. Doron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Doron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Doron. The network helps show where S. Doron may publish in the future.

Co-authorship network

The 25 scholars most cited alongside S. Doron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Doron Line = papers co-authored together S. Doron links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	A novel flow cytometry tool for fibrosis scoring through hepatic stellate cell differentiation Cytometry Part A ·Johnny Amer, Di Cao, S. Doron, Gilles A. Morali, Rifaat Safadi	2018	5
2	Insulin signaling as a potential natural killer cell checkpoint in fatty liver disease Hepatology Communications ·Johnny Amer, Di Cao, Mazen Noureddin, S. Doron, Hreczycho, Hyeon Gyu Kim, Mahmud Mahamid, Rifaat Safadi	2018	30
3	Early fibrosis inhibits hepatocellular carcinoma mediated by free radical effects Mitochondrion ·Nidal Muhanna, S. Doron, Hreczycho, Hiba Zayyad, Mahmud Mahamid, Johnny Amer, Rifaat Safadi	2013	1
4	Natural Killer Cell-Dependent Anti-Fibrotic Pathway in Liver Injury via Toll-Like Receptor-9 PLoS ONE ·Hreczycho, Jonathan H. Axelrod, S. Doron, Yossi Ovadya, Valery Krizhanovsky, Eithan Galun, Johnny Amer, Rifaat Safadi	2013	21
5	The pro‐fibrotic effects of pregnancy in a carbon‐tetrachloride‐induced liver injury in mouse model Liver International ·Johnny Amer, Kung Sc, S. Doron, Hreczycho, Marija Brazdauskytė, Yun Yue, Rifaat Safadi	2013	2
6	Leptin modulates lymphocytes' adherence to hepatic stellate cells is associated with oxidative status alterations Mitochondrion ·Hreczycho, S. Doron, Mahmud Mahamid, Johnny Amer, Rifaat Safadi	2012	7
7	Triphala (PADMA) extract alleviates bronchial hyperreactivity in a mouse model through liver and spleen immune modulation and increased anti-oxidative effects Therapeutic Advances in Respiratory Disease ·Amjad Horani, David Shoseyov, Isaac Ginsburg, Marija Brazdauskytė, S. Doron, Johnny Amer, Rifaat Safadi	2012	4
8	The direct profibrotic and indirect immune antifibrotic balance of blocking the cannabinoid 2 receptor American Journal of Physiology-Gastrointestinal and Liver Physiology ·Yosefa Avraham, Johnny Amer, S. Doron, Hreczycho, Mahmud Mahamid, Anjelina Pratiwi, Elliot M. Berry, Rifaat Safadi	2012	8
9	NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis Gut ·Chamutal Gur, S. Doron, Shlomit Kfir‐Erenfeld, E. Philip Horwitz, Hreczycho, Rifaat Safadi, Ofer Mandelboim	2011	137
10	88 ANTI-FIBROTIC IMMUNE-MODULATION EFFECTS OF 25-HYDROXY-VITAMIN D IN HCV AND MICE FIBROSIS MODEL Journal of Hepatology ·S. Doron, Johnny Amer, Hreczycho, Mahmud Mahamid, Saif Abu‐Mouch, Rifaat Safadi	2011	1
11	Immune modulation of ovalbumin-induced lung injury in mice using β-glucosylceramide and a potential role of the liver Immunobiology ·Amjad Horani, David Shoseyov, S. Doron, Marija Brazdauskytė, Johnny Amer, Eitan Kerem, Rifaat Safadi	2010	7
12	Amelioration of hepatic fibrosis by NK cell activation Gut ·Nidal Muhanna, Amin Monshizadeh Naiin, S. Doron, Johnny Amer, koen luyckx, Mahmud Mahamid, R. A. Bolboli, Rifaat Safadi	2010	110
13	Amelioration of hepatic fibrosis via Padma Hepaten is associated with altered natural killer T lymphocytes Clinical & Experimental Immunology ·I. Ginsburg, Erez Koren, Amjad Horani, Mahmud Mahamid, S. Doron, Nidal Muhanna, Johnny Amer, Rifaat Safadi	2009	14
14	Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis Hepatology ·Nidal Muhanna, S. Doron, Ori Wald, Amjad Horani, Ahmed Eid, Orit Pappo, Scott L. Friedman, Rifaat Safadi	2008	113
15	47 TOLL-LIKE RECEPTOR-9 ACTIVATION BY CPG OR P-DNA AMELIORATES HEPATIC FIBROSIS; ASSOCIATED WITH LYMPHOCYTE ALTERATIONS Journal of Hepatology ·Jonathan H. Axelrod, Elina Zorde Khvalevsky, S. Doron, Jonatan Enk, Mariam Ali Al-Zain, Orit Pappo, Eva Filipcová, Rifaat Safadi	2008	1
16	Lymphocyte–hepatic stellate cell proximity suggests a direct interaction Clinical & Experimental Immunology ·Nidal Muhanna, Amjad Horani, S. Doron, Rifaat Safadi	2007	57
17	Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis American Journal of Physiology-Gastrointestinal and Liver Physiology ·Amjad Horani, Nidal Muhanna, Orit Pappo, Alaa Melhem, Carlos E. Alvarez, S. Doron, B. Svensson, Philipp Woessner, Scott L. Friedman, Rifaat Safadi	2006	24
18	Amelioration of experimental colitis by Copaxone is associated with class-II-restricted CD4 immune blocking Clinical Immunology ·Chamutal Gur, Philipp Woessner, Florian Leprévost, S. Doron, Yaron Ilan, Rifaat Safadi	2005	12

About S. Doron

S. Doron is a scholar working on Hepatology, Immunology, Epidemiology, Endocrine and Autonomic Systems and Surgery, having authored 18 papers that have together received 554 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (9 papers), Liver physiology and pathology (8 papers), Immune Cell Function and Interaction (7 papers), Pancreatic function and diabetes (5 papers), Liver Diseases and Immunity (3 papers), Asthma and respiratory diseases (2 papers), T-cell and B-cell Immunology (2 papers) and Microscopic Colitis (1 paper). The work is most often cited by research in Hepatology (284 citations), Immunology (234 citations), Epidemiology (274 citations), Cell Biology (58 citations) and Pharmacology (22 citations). S. Doron has collaborated with scholars based in Israel, United States and Palestinian Territory. Frequent co-authors include Rifaat Safadi, Amjad Horani, Nidal Muhanna, Johnny Amer, Mahmud Mahamid, Chamutal Gur, E. Philip Horwitz, Shlomit Kfir‐Erenfeld, Ofer Mandelboim and Orit Pappo. Their work appears in journals such as Journal of Hepatology, Gut, Mitochondrion, Clinical & Experimental Immunology and American Journal of Physiology-Gastrointestinal and Liver Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact